Estée Lauder and Puig Explore $40 Billion Merger to Anchor Luxury Fragrance Sector
Estée Lauder and Spanish group Puig are in discussions for a potential business combination aimed at dominating the luxury fragrance market and competing with L'Oréal.
By: AXL Media
Published: Mar 24, 2026, 6:41 AM EDT
Source: People

Strategic Consolidation Against Industry Giants
The primary driver behind the potential merger is the need for greater scale to compete with industry leader L'Oréal and luxury conglomerate LVMH. The beauty sector has seen a wave of consolidation recently, notably L'Oréal’s $4.7 billion acquisition of Kering’s beauty business, which included the prestigious Creed fragrance line. A merger between Estée Lauder and Puig would fill significant gaps in Estée’s current portfolio, particularly in the high-growth "prestige fragrance" category, where Puig currently derives over 70% of its revenue.
Navigating Cooling Demand and Economic Headwinds
The discussions coincide with a normalization of the "revenge spending" trend that fueled the beauty industry following the pandemic. While Gen Z consumers have adopted fragrances as a daily staple—driving a 9% jump in Estée’s fragrance unit last quarter—broader economic pressures in the Americas have dampened overall growth. Analysts suggest that while the merger offers long-term strategic benefits, it could temporarily complicate Estée Lauder’s ongoing turnaround efforts by adding integration complexities during a period of sluggish U.S. consumer spending.
Financial Performance and Market Reaction
Market response to the news was a study in contrasts. Estée Lauder (EL.N) saw its shares drop more than 7% as investors weighed the risks of a massive integration against the company’s existing turnaround plans. Conversely, Puig (PUIGb.MC) shares surged approximately 16% on Tuesday, marking its best trading day since its 2024 IPO. The disparity reflects investor optimism regarding Puig’s increased global footprint versus concerns over Estée Lauder’s ability to remain nimble while absorbing a major international competitor.
Categories
Topics
Related Coverage
- Sun Pharmaceutical Launches Ambitious Twelve Billion Dollar Acquisition Bid For Women’s Health Specialist Organon
- Rising Operational Pressures Force Closure Of Longstanding Singapore Burger Landmark Working Title After Thirteen Years Of Service
- Warner Bros. Discovery Shareholders Approve $110 Billion Paramount Merger Amid David Zaslav Pay Row
- Parks Tau Targets Invasive Spam Calls With Strict New Consumer Protection Registry Mandate